The use of chitosan as the wall of microcapsule designed for delivery of encapsulated celecoxib is reported. Microcapsules were characterised with respect to size and encapsulation efficiency of celecoxib. In vivo animals demonstrated that both free celecoxib administration and chitosan/celecoxib microcapsules administration lead to a significant inhibition of cyclooxygenase-2 protein expression in the hepatocytes when compared with vehicle control mice. Interestingly, microcapsule containing celecoxib showed a better inhibition of cyclooxygenase-2 protein expression when compared with a simple oral administration of free celecoxib. Gas-chromatography-mass-spectrometry analysis showed that in mice treated with free celecoxib or chitosan/celecoxib microcapsules, their plasma concentration of celecoxib was similar. Microcapsules-based biomaterials as oral drug delivery vehicles may help to improve the absorption efficiency of therapeutic drugs.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2010.05.054DOI Listing

Publication Analysis

Top Keywords

chitosan/celecoxib microcapsules
12
free celecoxib
12
inhibition cyclooxygenase-2
8
cyclooxygenase-2 protein
8
protein expression
8
celecoxib
7
synthesis characterization
4
characterization preliminary
4
preliminary analysis
4
analysis vivo
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!